Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 1463 entries
View as:

Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06323382 Org: User:
Start: 01/01/21 End: 12/30/24 Due: 12/30/25

Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03908359 Org: User:
Start: 01/01/19 End: 12/31/23 Due: 12/31/24

Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04028778 Org: User:
Start: 04/10/19 End: 12/31/22 Due: 12/31/23

The Efficacy of an Artificial Intelligence Platform to Adapt Visual Aids for Patients With Low Vision: a Randomised Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT04919837 Org: User:
Start: 07/27/20 End: 07/30/21 Due: 07/30/22

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02289807 Org: User:
Start: 03/31/15 End: 08/31/22 Due: 08/31/23

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Phase: N/A Priority: Normal
NCT ID: NCT04436965 Org: User:
Start: 08/16/21 End: 12/15/24 Due: 12/15/25

Effectiveness Evaluation of the "Mosquito-Free Campus" Initiative on Dengue Fever Prevention and Control: A Cluster Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT07002021 Org: User:
Start: 06/15/25 End: 06/01/26 Due: 06/01/27

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT01765088 Org: User:
Start: 09/30/12 End: 12/31/19 Due: 12/31/20

Artificial Intelligence-assissted Glaucoma Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT03268031 Org: User:
Start: 08/15/17 End: 02/01/20 Due: 02/01/21

The Evolutionary Model of Mild-to-moderate Myopia in China

Phase: N/A Priority: Normal
NCT ID: NCT02667509 Org: User:
Start: 01/31/05 End: 10/31/15 Due: 10/31/16

Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01996098 Org: User:
Start: 01/01/14 End: 02/15/24 Due: 02/15/25

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

Phase: N/A Priority: Normal
NCT ID: NCT05116579 Org: User:
Start: 10/31/21 End: 08/31/25 Due: 08/31/26

PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02705508 Org: User:
Start: 02/29/16 End: 12/31/23 Due: 12/31/24

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04627012 Org: User:
Start: 01/01/18 End: 07/01/23 Due: 07/01/24

Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection

Phase: N/A Priority: Normal
NCT ID: NCT05231174 Org: User:
Start: 05/01/23 End: 07/30/23 Due: 07/30/24

The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT04961918 Org: User:
Start: 07/13/21 End: 07/13/23 Due: 07/13/24

Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03203590 Org: User:
Start: 09/30/17 End: 01/31/26 Due: 01/31/27

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04170179 Org: User:
Start: 11/19/19 End: 04/01/21 Due: 04/01/22

Effects and Mechanisms of n-3 PUFAs and Irisin on Abnormal Glucose Metabolism After GDM.

Phase: N/A Priority: Normal
NCT ID: NCT03023293 Org: User:
Start: 03/10/17 End: 12/31/19 Due: 12/31/20

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02992392 Org: User:
Start: 12/31/16 End: 06/30/17 Due: 06/30/18

The Intervention of Multi-vitamin With Minerals to Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT03218709 Org: User:
Start: 01/31/17 End: 04/30/18 Due: 04/30/19

Intraocular Lens-shell Technique in Phacoemulsification

Phase: N/A Priority: Normal
NCT ID: NCT02138123 Org: User:
Start: 12/31/11 End: 06/30/13 Due: 06/30/14

Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT02505113 Org: User:
Start: 10/31/10 End: - Due: -

Comparison of In-the-bag Stability Between Single-piece and Three-piece Intraocular Lens

Phase: N/A Priority: Normal
NCT ID: NCT02609997 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06127433 Org: User:
Start: 03/07/23 End: 12/30/24 Due: 12/30/25